# Synthetic Vaccine Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synthetic-vaccine-biotech

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Series B (Jul 21, 2025)
- Investors on record: 1

## About

Founded in 2020 and based in Beijing, China, Synthetic Vaccine Biotech, formerly known as Beijing Yufan Biotechnology Co., Ltd., focuses on the development of vaccines, adjuvants, and antibody-based therapies. The company operates as a biotechnology firm serving the biopharmaceutical sector. In July 2025, the company completed its Series B funding round. The company specializes in vaccine development, adjuvant technologies and antibody-drug conjugates (ADCs), along side wit biomedical research to support clinical applications and commercialization of therapeutic and preventive products in the life sciences sector. The company generates revenue through research collaboration, licensing agreements, and the development and commercialization of vaccines and therapeutic antibody products. The company plans to enhance core technology platforms and accelerate the development and translation of its product pipeline with the proceed from the latest funding round.

## Funding rounds

- Series B, Jul 21, 2025 — Lapam Capital

## Investors

- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series B